Cytiva is a global provider of technologies and services that support the development and manufacture of biopharmaceuticals. The company specializes in areas such as bioprocessing, cell and gene therapy, and protein analysis. Cytiva's products and solutions are utilized by researchers and manufacturers in the life sciences sector, aiming to enhance the efficiency and effectiveness of biopharmaceutical production.
Originally part of GE Healthcare, Cytiva became an independent entity in 2020. The company is known for its commitment to innovation and collaboration within the biopharmaceutical industry, providing tools and expertise that help accelerate the development of new therapies. With a focus on advancing science, Cytiva plays a significant role in supporting the global health landscape, particularly in the context of increasing demand for biopharmaceuticals.
Cytiva operates in various locations worldwide, including Uppsala, where it has a notable presence. The Uppsala facility contributes to the company's research and development efforts, emphasizing the importance of local operations in driving global initiatives within the biopharmaceutical field.